e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The development of pulmonary hypertension after first episode of acute pulmonary embolism and related risk factors
S. Zhang, Z. Zhai, Y. Yang, T. Kuang, C. Wang (Beijing, China)
Source:
Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Session:
Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Session type:
Poster Discussion
Number:
1494
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Zhang, Z. Zhai, Y. Yang, T. Kuang, C. Wang (Beijing, China). The development of pulmonary hypertension after first episode of acute pulmonary embolism and related risk factors. Eur Respir J 2012; 40: Suppl. 56, 1494
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Features of patients newly diagnosed pulmonary embolism during COVID pneumonia
Related content which might interest you:
Chronic thromboembolic pulmonary hypertension in acute pulmonary embolism: A risk factor evaluation study
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020
Incidence of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011
Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2012; 21: 27-31
Year: 2012
The incidence of venous thromboembolism recurrence in patients after first episode acute pulmonary embolism and related risk factors
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
Pulmonary embolism and the consequences for the right heart
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=136
Year: 2006
Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010
Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism
Source: Eur Respir J, 55 (6) 2000189; 10.1183/13993003.00189-2020
Year: 2020
The relationship of thrombus localization with prognosis and chronic tromboembolic pulmonary hypertension in acute pulmonary thromboembolia
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020
Predicting recurrent pulmonary embolism and chronic thromboembolic pulmonary hypertension: one more way to skin the cat
Source: Eur Respir J, 49 (5) 1700413; 10.1183/13993003.00413-2017
Year: 2017
Prevalence of chronic thromboembolic pulmonary hypertension 2 years after pulmonary embolism
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008
Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients.
Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies
Year: 2018
Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018
Year: 2019
Prevalence of chronic thromboembolic pulmonary hypertension (CTEPH) in patients after pulmonary embolism
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018
Prognostic value of the ECG on admission in patients with acute major pulmonary embolism
Source: Eur Respir J 2005; 25: 843-848
Year: 2005
The genetic risk factors for the recurrent pulmonary embolism
Source: Eur Respir J 2005; 26: Suppl. 49, 100s
Year: 2005
Incidence of recurrent thromboembolism and chronic thromboembolic pulmonary hypertension after pulmonary embolism
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011
Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2009; 33: 325-331
Year: 2009
The frequency of chronic thromboembolic pulmonary hypertension and associated risk factors
Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept